Sugi Predict

Sugi Predict / Compounds / SCHEMBL10196078

SCHEMBL10196078

SCHEMBL10196078

COc1cc(C)cc(OC)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.59
▸ NPC1 O15118 3/20 0.44
▸ GAA P10253 2/20 0.44
▸ MAPT P10636 6/20 0.42
▸ HPGD P15428 5/20 0.42
▸ L3MBTL1 Q9Y468 5/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPK1 P28482 3/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ ERN1 O75460 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19286921 0.87 ACHE (0.52) ACHENPC1GAAMAPTHPGD
SCHEMBL14500122 0.87 ACHE (0.52) ACHENPC1GAAMAPTHPGD
SCHEMBL10935658 0.84 ACHE (0.48) ACHENPC1GAAMAPTHPGD
SCHEMBL17736226 0.84 ALDH1A1 (0.52) ACHENPC1GAAMAPTHPGD
SCHEMBL14500126 0.84 ACHE (0.48) ACHENPC1GAAMAPTHPGD
SCHEMBL16134099 0.80 ACHE (0.45) ACHENPC1GAAMAPTHPGD
SCHEMBL14500123 0.80 ACHE (0.45) ACHEGAAMAPTHPGDL3MBTL1
SCHEMBL18652581 0.80 ACHE (0.45) ACHENPC1GAAMAPTHPGD
SCHEMBL14500125 0.79 ACHE (0.43) ACHENPC1GAAMAPTHPGD
SCHEMBL15883267 0.78 ALDH1A1 (0.53) GAAMAPTHPGDALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 — — US disclosed
WO-2019034009-A1 Btk INHIBITORS WITH IMPROVED DUAL SELECTIVITY BEIGENE, LTD. (KY) 2019-02-21 — — WO disclosed
EP-3137462-B1 PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF A PDE10 INHIBITOR OMEROS CORP (US) 2019-01-30 — — EP disclosed
US-9982087-B2 Method for producing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-29 — — US disclosed
US-9744186-B2 Substituted gemcitabine aryl amide analogs NUCORION PHARMACEUTICALS, INC. (US) 2017-08-29 — — US disclosed
US-9447137-B2 Substituted gemcitabine aryl amide analogs NUCORION PHARMACEUTICALS, INC. (US) 2016-09-20 — — US disclosed
US-20160200861-A1 METHOD FOR PRODUCING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-07-14 — — US disclosed
EP-3037398-A1 METHOD FOR MANUFACTURING CHEMICAL COMPOUND Sumitomo Chemical Company, Limited (JP) 2016-06-29 — — EP disclosed
US-9187478-B2 Substituted naphthyridines and their use as medicaments Boehringer Ingellheim International GmbH (DE) 2015-11-17 — — US disclosed
US-20150259375-A1 SUBSTITUTED GEMCITABINE ARYL AMIDE ANALOGS THE OHIO STATE UNIVERSITY 2015-09-17 — — US disclosed
US-20150126503-A1 SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2015-05-07 — — US disclosed
US-8969568-B2 Substituted naphthyridines and their use as medicaments BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2015-03-03 — — US disclosed
US-8236965-B2 Benzimidazole derivatives and their use as a medicament IPSEN PHARMA S.A.S. (FR) 2012-08-07 — — US disclosed
US-20120028939-A1 SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-02 — — US disclosed
WO-2011092128-A1 SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS SYK KINASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-08-04 — — WO disclosed
US-20090170922-A1 Benzimidazole derivatives and their use as a medicament SOCIETE DE CONSEILS DE RECHERECHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2009-07-02 — — US disclosed
US-7495110-B2 Benzimidazole derivatives and their use as GnRH antagonists SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-02-24 — — US disclosed
US-4076810-A Benzylpyrimidine antibacterial composition HOFFMANN-LA ROCHE INC. (US) 1978-02-28 — — US disclosed
US-4024145-A Benzylpyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 1977-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors CDK1, CDKN1A, CDKL1 ACHE 4804/4885NPC1 3001/4885GAA 4060/4885
US-20120028939-A1 SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS MEDICAMENTS NR4A3, NR0B1, NR4A1 ACHE 1308/4885NPC1 412/4885GAA 3686/4885
US-20150259375-A1 SUBSTITUTED GEMCITABINE ARYL AMIDE ANALOGS TYMP, GMNN, SAMHD1 ACHE 4443/4885NPC1 712/4885GAA 122/4885
US-20090170922-A1 Benzimidazole derivatives and their use as a medicament GNRHR, FSHR, KISS1R ACHE 1378/4885NPC1 3830/4885GAA 893/4885
US-20150126503-A1 SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS MEDICAMENTS NR4A3, NR0B1, NR4A1 ACHE 1308/4885NPC1 412/4885GAA 3686/4885
US-20160200861-A1 METHOD FOR PRODUCING COMPOUND NUDT1, OSGEP, CNOT9 ACHE 2463/4885NPC1 377/4885GAA 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.